
The Chinese government approved Swiss drugmaker Roche's anti-inflammation drug Actemra to treat severe coronavirus symptoms. This comes at a time when countries around the world desperately search for new ways to combat the deadly infection.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39owtsd
via
IFTTT
0 comments:
Post a Comment